Myomo — Third Quarter 2026 Earnings Summary

Myomo reported record third-quarter 2026 revenue of $12.3 million, representing a 22% year-over-year increase driven by a 19% rise in units sold and a 2% increase in average selling price. The company achieved breakeven Adjusted EBITDA for the quarter, with gross margins expanding to 71.3% and 54% of revenue originating from recurring patient sources. Myomo updated its full-year revenue guidance to $46-47 million and expects cash burn to remain under $2 million for the second half of the year.